Business, energy, technology, markets and global industry news from Business News Today
Pharma & Biotech

CVS Health’s compact Houston pharmacy could reveal where America’s drugstores are heading

CVS Health opens a pharmacy-focused Houston store as its smaller format tests whether better access can coexist with stronger retail economics for patients.

Read More
Pharma & Biotech

Can one gene therapy cut years of eye injections? REGENXBIO’s five-year data raise the stakes

REGENXBIO reports five-year wet AMD durability and 2.5-year diabetic retinopathy data as pivotal sura-vec milestones approach.

Read More
Medical Devices & Diagnostics

Why MultiDimension Technology’s tiny 50 nA chip could matter before a CGM is ever worn

MultiDimension Technology’s TMR1370 targets two-year CGM standby with 50 nA current, but device-level validation will decide its impact.

Read More
Medical Devices & Diagnostics

Six medical societies want radiation safety upgraded. Can Salus Scientific turn consensus into hospital adoption?

Salus Scientific gains a strategic tailwind as six medical societies urge hospitals to adopt enhanced radiation protection in fluoroscopy labs.

Read More
Medical Devices & Diagnostics

Eurofins Viracor’s three new blood assays look fast, but can they change transplant monitoring?

Eurofins Viracor adds rapid CXCL9, CXCL10 and IL-18 plasma assays, but clinical utility, logistics and reimbursement will shape adoption.

Read More
Pharma & Biotech

Vanda’s imsidolimab has won a rare European advantage, but one approved rival changes the equation

Vanda’s imsidolimab gains an EMA orphan recommendation for GPP, but approval, differentiation and European access remain ahead.

Read More
Pharma & Biotech

CAM2029 is back before the FDA, but has Camurus finally cleared its manufacturing hurdle?

Camurus has restored a formal United States review timeline for CAM2029, but the December decision remains tied to third-party manufacturing compliance rather than new questions about clinical efficacy.

Read More
Pharma & Biotech

Could calpurbatug spare infected joint implants? Trellis Bioscience raises $9m to find out

Trellis Bioscience raises $9 million to complete a Phase 2 trial testing calpurbatug and implant retention in chronic joint infections.

Read More
Medical Devices & Diagnostics

How QIAGEN’s FDA-cleared QIAstat-Dx test supports the Cyclospora outbreak response

QIAGEN highlights its FDA-cleared QIAstat-Dx panel as U.S. Cyclospora cases rise, while research tools support outbreak tracing.

Read More
Medical Devices & Diagnostics

Can one ventilator protect the lungs and diaphragm together? Nihon Kohden puts NKV-550 to the test

Nihon Kohden adds Pmus monitoring and adaptive controls to NKV-550, but hospital adoption will depend on validation and workflow performance.

Read More